dm+d

Unassigned

New Medicines

Intestinal malabsorption in preterm neonates - first-line

Information

New molecular entity
Nutrinia
Nutrinia

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

An oral human insulin powder for reconstitution, comprising insulin with excipients (already approved for infant consumption). NTRA 2112 has a stable shelf-life and targets local gastrointestinal tract with no systemic absorption.
In 2015, the highest percentage of births before 37 weeks gestation occurred in the Black Caribbean ethnic group with 10.7% of births being classed as preterm. The White Other ethnic group has the lowest percentage of preterm births with 6.6% of live births occurring before 37 weeks gestation [1].
Intestinal malabsorption in preterm neonates - first-line
Oral